There are limited treatment options available for chronic renal disorder (CKD), and patients often still reach renal failure or premature death / The phase III clinical trial study FIND-CKD will…
In an updated analysis on the adult subset of non-central systema nervosum (CNS) / TRK fusion cancer patients from three larotrectinib clinical trials, a high overall response rate (ORR) of…
Andes has developed novel seed treatment technology that allows crops to thrive without synthetic fertilizers / Funds will aid the development of revolutionary nature-based carbon capture technology Leaps by Bayer,…
Updated analyses for Vitrakvi™ (larotrectinib) reaffirm sustained clinical benefits for patients with TRK fusion cancer / Breadth of prostatic adenocarcinoma portfolio on display, including presentations for Nubeqa™ (darolutamide) in non-metastatic…
Significant improvement in 24-hour cough counts over placebo after 12 weeks of treatment and with a positive safety and tolerability profile / Results from PAGANINI Phase IIb dose-finding study presented…
Recommendation supported Data From Phase 3 KEYNOTE-355 Trial Merck, referred to as MSD outside the us and Canada, today announced the Committee for Medicinal Products for Human Use (CHMP) of…
Study Now Enrolling Participants Who sleep in an equivalent Household as Someone With Symptomatic, Laboratory-Confirmed COVID-19 Merck ,known as MSD outside the us and Canada, and Ridgeback Biotherapeutics announced today…
New data show pre-symptomatic babies with spinal muscular atrophy (SMA) treated with Evrysdi maintained the power to swallowEvrysdi has demonstrated consistent clinically meaningful efficacy in adults, children, and babies two…
Acute respiratory infections are one of the leading causes of death and disability globally, presenting substantial health challenges especially for infants, the elderly and the immunocompromised.1-3 Three new molecular diagnostic…
Roche today presented new data from the phase III clinical trial IMpower010 study at the ecu Society for Medical Oncology (ESMO) Congress 2021 Presidential Symposium, reinforcing the many disease-free survival…
The U.S. Food and Drug Administration today approved Byooviz (ranibizumab-nuna) because the first biosimilar to Lucentis (ranibizumab injection) for the treatment of several eye diseases and conditions, including neovascular (wet)…
The following quote is attributed to Acting FDA Commissioner Janet Woodcock, M.D “The opioid crisis continues to be a national public health emergency with devastating and far-reaching consequences extending into…